Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Transfluthrin is a fast-acting synthetic pyrethroid insecticide with low persistency, primarily used as a household insecticide and mosquito repellent. It is effective against flies, mosquitoes, moths, cockroaches, wasps, and hornets. Transfluthrin acts as both a contact and inhalation agent due to its relatively high volatility. Its mechanism of action involves modulation of insect voltage-gated sodium channels—specifically by inducing persistent currents in these channels—which leads to paralysis and death in insects. Transfluthrin is significantly more toxic to insects than mammals because of differences in sodium channel sensitivity and body physiology[1][5][6]. It is available commercially in products such as liquid vaporizers and mosquito coils for indoor use[3][5]. The compound has the molecular formula C15H12Cl2F4O2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on transfluthrin.